COLL vs MA · P/E 17, rev $181.9M vs P/E 38, rev $32.79B
Collegium Pharmaceutical Inc (COLL) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the COLL and MA stock pages for the full models.
Not investment advice.